Gabapentin Tablet, Coated
Product Images NDC 50090-7268

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-7268). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gabapenin 01)

Chemical Structure (Gabapenin 01)
Chemical structure of Gabapentin, showing a cyclohexane ring with attached amino and carboxyl functional groups.*
FDA Label Image

Figure 1 (Gabapenin 02)

Figure 1 (Gabapenin 02)
A line graph depicting the mean pain score over eight weeks comparing placebo and Gabapentin 3,600 mg/day. The x-axis represents weeks, including a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 9. Gabapentin treatment shows a decreasing pain score trend over time compared to placebo.*
FDA Label Image

Figure 2 (Gabapenin 03)

Figure 2 (Gabapenin 03)
A line graph depicting mean pain scores over 7 weeks during a 3-week dose titration period and a 4-week fixed dose period. The graph compares placebo, gabapentin 1,800 mg/day, and gabapentin 2,400 mg/day, showing changes in pain scores across the study duration.*
FDA Label Image

Figure 3 (Gabapenin 04)

Figure 3 (Gabapenin 04)
A bar chart illustrating results from two studies comparing percentages for placebo (PBO) and Gabapentin (GBP) treatment groups at different dosages. Study 1 shows PBO at 12% and GBP at 29% (3,600 mg). Study 2 compares PBO at 14%, GBP 1,800 mg at 32%, and GBP 2,400 mg at 34%, annotated with significance levels p < 0.01 and p < 0.001.*
FDA Label Image

Figure 4 (Gabapenin 05)

Figure 4 (Gabapenin 05)
A scatter plot graph showing percentage difference on the vertical axis against daily dose in mg on the horizontal axis. The graph compares data points across three studies labeled as STUDY a, STUDY b, and STUDY c, with doses ranging from 600 to 1800 mg. Each study is represented by different colored markers, and some points are annotated with letters a, b, or c.*
FDA Label Image

Label Image (Lbl500907268)

Label Image (Lbl500907268)
Gabapentin 600 mg coated tablets label from A-S Medication Solutions. The label states the product contains 600 mg of gabapentin per tablet and includes storage instructions to store at 77 degrees Fahrenheit. The package contains 90 tablets and is labeled for oral route use. The product NDC is 50090-7268.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.